Terms: = Liver cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
28 results:
1. Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease.
Ding Y; Dai X; Bao M; Xing Y; Liu J; Zhao S; Liu E; Yuan Z; Bai L
Animal Model Exp Med; 2023 Aug; 6(4):317-328. PubMed ID: 37565549
[TBL] [Abstract] [Full Text] [Related]
2. Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target.
Lohoff FW; Clarke TK; Kaminsky ZA; Walker RM; Bermingham ML; Jung J; Morris SW; Rosoff D; Campbell A; Barbu M; Charlet K; Adams M; Lee J; Howard DM; O'Connell EM; Whalley H; Porteous DJ; McIntosh AM; Evans KL
Mol Psychiatry; 2022 Mar; 27(3):1754-1764. PubMed ID: 34857913
[TBL] [Abstract] [Full Text] [Related]
3. Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets.
Zuo Q; Chen KL; Arredondo Eve A; Liu YJ; Kim SH; Katzenellenbogen BS; Katzenellenbogen JA; Madak-Erdogan Z
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684335
[TBL] [Abstract] [Full Text] [Related]
4. Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK.
Bao R; Meng Y; Zhang H; Yang C; Li W; Zhang C; Zhang J; Sun R; Li Z; Jiang W; Zhang C; Zhang C; Yuan HX; Dang Y
Cell Death Dis; 2021 Oct; 12(11):972. PubMed ID: 34671010
[TBL] [Abstract] [Full Text] [Related]
5. Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.
Patel VC; Lee S; McPhail MJW; Da Silva K; Guilly S; Zamalloa A; Witherden E; Støy S; Manakkat Vijay GK; Pons N; Galleron N; Huang X; Gencer S; Coen M; Tranah TH; Wendon JA; Bruce KD; Le Chatelier E; Ehrlich SD; Edwards LA; Shoaie S; Shawcross DL
J Hepatol; 2022 Feb; 76(2):332-342. PubMed ID: 34571050
[TBL] [Abstract] [Full Text] [Related]
6. The bioactive ingredients in Actinidia chinensis Planch. Inhibit liver cancer by inducing apoptosis.
Hong Z; Lu Y; Ran C; Tang P; Huang J; Yang Y; Duan X; Wu H
J Ethnopharmacol; 2021 Dec; 281():114553. PubMed ID: 34428524
[TBL] [Abstract] [Full Text] [Related]
7. Sodium
Salhab A; Amer J; Lu Y; Safadi R
Gut; 2022 Jul; 71(7):1373-1385. PubMed ID: 34266968
[TBL] [Abstract] [Full Text] [Related]
8. Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease.
Alqahtani SA; Broering DC; Alghamdi SA; Bzeizi KI; Alhusseini N; Alabbad SI; Albenmousa A; Alfaris N; Abaalkhail F; Al-Hamoudi WK
BMC Gastroenterol; 2021 Jun; 21(1):245. PubMed ID: 34074270
[TBL] [Abstract] [Full Text] [Related]
9. Exploration of the Potential Mechanism of Calculus Bovis in treatment of Primary liver cancer by Network Pharmacology.
Zhang Z; Zeng P; Gao W; Wu R; Deng T; Chen S; Tian X
Comb Chem High Throughput Screen; 2021; 24(1):129-138. PubMed ID: 32772910
[TBL] [Abstract] [Full Text] [Related]
10. CpG Islands Methylation Analysis of cdh11, EphA5, and HS3ST2 Genes in Gastric Adenocarcinoma Patients.
Eyvazi S; Khamaneh AM; Tarhriz V; Bandehpour M; Hejazi MS; Sadat ATE; Sepehri B
J Gastrointest Cancer; 2020 Jun; 51(2):579-583. PubMed ID: 31407253
[TBL] [Abstract] [Full Text] [Related]
11. Fat-specific protein 27 is a novel target gene of liver X receptor α.
Aibara D; Matsusue K; Takiguchi S; Gonzalez FJ; Yamano S
Mol Cell Endocrinol; 2018 Oct; 474():48-56. PubMed ID: 29454584
[TBL] [Abstract] [Full Text] [Related]
12. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
[TBL] [Abstract] [Full Text] [Related]
13. Leptin signaling molecular actions and drug target in hepatocellular carcinoma.
Jiang N; Sun R; Sun Q
Drug Des Devel Ther; 2014; 8():2295-302. PubMed ID: 25484575
[TBL] [Abstract] [Full Text] [Related]
14. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.
Tubbs E; Theurey P; Vial G; Bendridi N; Bravard A; Chauvin MA; Ji-Cao J; Zoulim F; Bartosch B; Ovize M; Vidal H; Rieusset J
Diabetes; 2014 Oct; 63(10):3279-94. PubMed ID: 24947355
[TBL] [Abstract] [Full Text] [Related]
15. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.
Shi X; Cheng Q; Xu L; Yan J; Jiang M; He J; Xu M; Stefanovic-Racic M; Sipula I; O'Doherty RM; Ren S; Xie W
Mol Cell Biol; 2014 Feb; 34(3):485-97. PubMed ID: 24277929
[TBL] [Abstract] [Full Text] [Related]
16. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism.
Ren G; Kim JY; Smas CM
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E334-51. PubMed ID: 22569073
[TBL] [Abstract] [Full Text] [Related]
17. Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
Wu W; Chen B; Cheng J; Wang J; Xu W; Liu L; Xia G; Wei H; Wang X; Yang M; Yang L; Zhang Y; Xu C; Li J
Int J Nanomedicine; 2010 Dec; 5():1079-84. PubMed ID: 21170355
[TBL] [Abstract] [Full Text] [Related]
18. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract] [Full Text] [Related]
19. Carbohydrate responsive element binding protein and lipid homeostasis.
Denechaud PD; Girard J; Postic C
Curr Opin Lipidol; 2008 Jun; 19(3):301-6. PubMed ID: 18460923
[TBL] [Abstract] [Full Text] [Related]
20. Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death.
Kim JY; Liu K; Zhou S; Tillison K; Wu Y; Smas CM
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E654-67. PubMed ID: 18198355
[TBL] [Abstract] [Full Text] [Related]
[Next]
